Published in Biochemistry on April 08, 1986
Biochemical characteristics and physiological significance of major DNA topoisomerases. Antimicrob Agents Chemother (1989) 1.55
ATP-independent type II topoisomerase from trypanosomes. Proc Natl Acad Sci U S A (1986) 1.16
Activity of fluoroquinolone antibiotics against Plasmodium falciparum in vitro. Antimicrob Agents Chemother (1988) 1.15
DNA topoisomerases in apicomplexan parasites: promising targets for drug discovery. Proc Biol Sci (2010) 1.02
In vitro study of anticancer acridines as potential antitrypanosomal and antimalarial agents. Antimicrob Agents Chemother (1992) 1.00
In vitro assays used to measure the activity of topoisomerases. Antimicrob Agents Chemother (1990) 0.98
Glycosylated flavones as selective inhibitors of topoisomerase IV. Antimicrob Agents Chemother (1997) 0.97
Structure-activity relationships and modes of action of 9-anilinoacridines against chloroquine-resistant Plasmodium falciparum in vitro. Antimicrob Agents Chemother (1993) 0.94
Involvement of topoisomerases in replication, transcription, and packaging of the linear adenovirus genome. J Virol (1990) 0.85
Activities of pefloxacin and ciprofloxacin against experimental malaria in mice. Antimicrob Agents Chemother (1990) 0.81
Type II topoisomerase activities in both the G1 and G2/M phases of the dinoflagellate cell cycle. Chromosoma (2005) 0.81
Hyperthermia, thermotolerance and topoisomerase II inhibitors. Br J Cancer (1995) 0.79
Functional expression of a DNA-topoisomerase IB from Cryptosporidium parvum. J Biomed Biotechnol (2009) 0.76
Cyclin activation of p34cdc2. Cell (1990) 6.87
Mitotic spindle organization by a plus-end-directed microtubule motor. Nature (1992) 6.52
Human cyclin E, a new cyclin that interacts with two members of the CDC2 gene family. Cell (1991) 4.88
Termination of translation in eukaryotes is governed by two interacting polypeptide chain release factors, eRF1 and eRF3. EMBO J (1995) 4.66
A highly conserved eukaryotic protein family possessing properties of polypeptide chain release factor. Nature (1994) 4.21
The Bloom's syndrome gene product interacts with topoisomerase III. J Biol Chem (2000) 3.52
Two distinct mechanisms alter p53 in breast cancer: mutation and nuclear exclusion. Proc Natl Acad Sci U S A (1992) 3.27
The Xenopus protein kinase pEg2 associates with the centrosome in a cell cycle-dependent manner, binds to the spindle microtubules and is involved in bipolar mitotic spindle assembly. J Cell Sci (1998) 2.67
Cloning by differential screening of a Xenopus cDNA coding for a protein highly homologous to cdc2. Proc Natl Acad Sci U S A (1991) 2.60
Wild-type p53 protein undergoes cytoplasmic sequestration in undifferentiated neuroblastomas but not in differentiated tumors. Proc Natl Acad Sci U S A (1995) 2.56
Eukaryotic polypeptide chain release factor eRF3 is an eRF1- and ribosome-dependent guanosine triphosphatase. RNA (1996) 2.48
Specific phosphorylation of SR proteins by mammalian DNA topoisomerase I. Nature (1996) 2.45
The C-terminal cytoplasmic Lys-thr-X-X-X-Trp motif in frizzled receptors mediates Wnt/beta-catenin signalling. EMBO J (2000) 2.40
Early events in DNA replication require cyclin E and are blocked by p21CIP1. J Cell Biol (1995) 2.34
Ancient DNA analysis reveals divergence of the cave bear, Ursus spelaeus, and brown bear, Ursus arctos, lineages. Curr Biol (2001) 2.11
Characterization of a human ovarian adenocarcinoma line, IGROV1, in tissue culture and in nude mice. Cancer Res (1985) 2.06
Alternative splicing directs the expression of two D2 dopamine receptor isoforms. Nature (1990) 2.04
Expression of prostate-specific antigen and prostate-specific membrane antigen transcripts in blood cells: implications for the detection of hematogenous prostate cells and standardization. Clin Chem (1998) 1.99
Cloning by differential screening of a Xenopus cDNA that encodes a kinesin-related protein. Mol Cell Biol (1991) 1.95
Poly(A) metabolism and polysomal recruitment of maternal mRNAs during early Xenopus development. Dev Biol (1990) 1.93
The S. pombe aurora-related kinase Ark1 associates with mitotic structures in a stage dependent manner and is required for chromosome segregation. J Cell Sci (2001) 1.71
Complete nucleotide sequence of minicircle kinetoplast DNA from Trypanosoma equiperdum. Proc Natl Acad Sci U S A (1981) 1.56
Electron microscopy of the circular kinetoplastic DNA from Trypanosoma cruzi: occurrence of catenated forms. Proc Natl Acad Sci U S A (1969) 1.49
Study of the 10-nm-filament fraction isolated during the standard microtubule preparation. Biochem J (1980) 1.49
A panel of antibodies for the immunostaining of Bouin's fixed bone marrow trephine biopsies. J Clin Pathol (1997) 1.49
Telomerase inhibitors based on quadruplex ligands selected by a fluorescence assay. Proc Natl Acad Sci U S A (2001) 1.48
Lipid traffic between high density lipoproteins and Plasmodium falciparum-infected red blood cells. J Cell Biol (1991) 1.43
Cyclin A potentiates maturation-promoting factor activation in the early Xenopus embryo via inhibition of the tyrosine kinase that phosphorylates cdc2. J Cell Biol (1992) 1.43
Specific inhibition of serine- and arginine-rich splicing factors phosphorylation, spliceosome assembly, and splicing by the antitumor drug NB-506. Cancer Res (2001) 1.42
Beta-thalassaemia in indigenous Belgians: an update. Acta Clin Belg (1997) 1.39
Changes in the polyadenylation of specific stable RNA during the early development of Xenopus laevis. Gene (1988) 1.38
Structure and expression of c-erbB-2 and EGF receptor genes in inflammatory and non-inflammatory breast cancer: prognostic significance. Int J Cancer (1989) 1.35
Cytological and immunological responses to Babesia divergens in different hosts: ox, gerbil, man. Parasitol Res (1991) 1.33
Preparation and properties of nuclear and satellite deoxyribonucleic acid of Trypanosoma cruzi. J Mol Biol (1967) 1.31
Overexpression of human release factor 1 alone has an antisuppressor effect in human cells. Mol Cell Biol (1997) 1.30
Sustained increase in aortic endothelial nitric oxide synthase expression in vivo in a model of chronic high blood flow. Circ Res (1996) 1.29
Hormonal and cardiac effects of converting enzyme inhibition in rat myocardial infarction. Circ Res (1988) 1.24
The kinesin-related protein Eg5 associates with both interphase and spindle microtubules during Xenopus early development. Dev Biol (1994) 1.24
Replicating, convalently closed, circular DNA from kinetoplasts of Trypanosoma cruzi. Proc Natl Acad Sci U S A (1972) 1.23
Purification and characterization of human DNA topoisomerase IIIalpha. Nucleic Acids Res (1999) 1.22
Ethidium derivatives bind to G-quartets, inhibit telomerase and act as fluorescent probes for quadruplexes. Nucleic Acids Res (2001) 1.22
In Xenopus laevis, the product of a developmentally regulated mRNA is structurally and functionally homologous to a Saccharomyces cerevisiae protein involved in translation fidelity. Mol Cell Biol (1993) 1.18
ATP-independent type II topoisomerase from trypanosomes. Proc Natl Acad Sci U S A (1986) 1.16
Overexpression of either c-myc or c-erbB-2/neu proto-oncogenes in human breast carcinomas: correlation with poor prognosis. Oncogene Res (1988) 1.16
Strong association between c-myb and oestrogen-receptor expression in human breast cancer. Oncogene (1990) 1.16
3-Hydroxy-3-methylglutaryl coenzyme A reductase inhibitors lovastatin and simvastatin inhibit in vitro development of Plasmodium falciparum and Babesia divergens in human erythrocytes. Antimicrob Agents Chemother (1994) 1.14
Bone marrow transplantation in sickle cell anaemia. Arch Dis Child (1991) 1.14
Effect of chronic ANG I-converting enzyme inhibition on aging processes. II. Large arteries. Am J Physiol (1994) 1.12
Preclinical evaluation of docetaxel (Taxotere). Semin Oncol (1995) 1.11
Identification and properties of a major plasma metabolite of irinotecan (CPT-11) isolated from the plasma of patients. Cancer Res (1996) 1.11
Topology of the fibrinolytic system within the mural thrombus of human abdominal aortic aneurysms. J Pathol (2007) 1.11
Functional interaction between the bovine papillomavirus virus type 1 replicative helicase E1 and cyclin E-Cdk2. J Virol (1998) 1.11
The product of the mammalian orthologue of the Saccharomyces cerevisiae HBS1 gene is phylogenetically related to eukaryotic release factor 3 (eRF3) but does not carry eRF3-like activity. FEBS Lett (1998) 1.11
Interaction of human DNA topoisomerase I with G-quartet structures. Nucleic Acids Res (2000) 1.09
Circulating and cellular markers of endothelial dysfunction with aging in rats. Am J Physiol (1997) 1.09
Correlation of MDR1 gene expression with chemotherapy in neuroblastoma. J Natl Cancer Inst (1989) 1.08
A cdc2-related kinase oscillates in the cell cycle independently of cyclins G2/M and cdc2. J Biol Chem (1992) 1.08
C-myc proto-oncogene expression and prognosis in early carcinoma of the uterine cervix. Lancet (1987) 1.08
P190 BCR/ABL transcript in a case of Philadelphia-positive multiple myeloma. Leukemia (1990) 1.07
Expression of a human multidrug resistance gene in ovarian carcinomas. Cancer Res (1989) 1.06
Absence of kinetoplast DNA in a late antigenic variant of Trypanosoma equiperdum. Mol Biochem Parasitol (1980) 1.06
Human ARF protein interacts with topoisomerase I and stimulates its activity. Oncogene (2001) 1.05
Eukaryotic release factor 1 (eRF1) abolishes readthrough and competes with suppressor tRNAs at all three termination codons in messenger RNA. Nucleic Acids Res (1997) 1.04
Jurassic-Early Cretaceous Gondwanan homoxylous woods: a nomenclatural revision of the genera with taxonomic notes. Rev Palaeobot Palynol (2001) 1.03
Kinetics of lactone hydrolysis in antitumor drugs of camptothecin series as studied by fluorescence spectroscopy. Biochim Biophys Acta (1998) 1.03
Properties, stage-dependent expression and localization of Plasmodium falciparum M1 family zinc-aminopeptidase. Parasitology (2002) 1.02
Abnormal circular DNA molecules induced by ethidium bromide in the kinetoplast of Trypanosoma cruzi. Proc Natl Acad Sci U S A (1969) 1.02
Interaction of an acridine dimer with DNA quadruplex structures. J Biomol Struct Dyn (2001) 1.01
Enhanced binding to DNA and topoisomerase I inhibition by an analog of the antitumor antibiotic rebeccamycin containing an amino sugar residue. Mol Pharmacol (1999) 1.01
Left ventricular fibrosis in renovascular hypertensive rats. Effect of losartan and spironolactone. Hypertension (1995) 1.01
Xenopus cyclin E, a nuclear phosphoprotein, accumulates when oocytes gain the ability to initiate DNA replication. J Cell Sci (1996) 1.01
[Fractionation and characterization of desoxyribonucleic acid (DNA) of trypanosomes (Trypanosoma equiperdum)]. C R Acad Sci Hebd Seances Acad Sci D (1966) 1.00
Modulation of DNA topoisomerase I activity by p53. Biochemistry (1996) 1.00
Chronic blockade of NO synthase activity induces a proinflammatory phenotype in the arterial wall: prevention by angiotensin II antagonism. Arterioscler Thromb Vasc Biol (1998) 0.99
[A functional flagella with a 6 + 0 pattern]. J Cell Biol (1975) 0.99
DNA cleavage by topoisomerase I in the presence of indolocarbazole derivatives of rebeccamycin. Biochemistry (1997) 0.97
Molecular characterization of femA from Staphylococcus hominis and Staphylococcus saprophyticus, and femA-based discrimination of staphylococcal species. Res Microbiol (1999) 0.97
Occurrence of a kinetoplast DNA-protein complex in Trypanosoma cruzi. Biochem Biophys Res Commun (1981) 0.97
Loss of heterozygosity, allele silencing and decreased expression of p73 gene in breast cancers: prevalence of alterations in inflammatory breast cancers. Oncogene (2000) 0.96
Multivariate data analysis using D-optimal designs, partial least squares, and response surface modeling: A directional approach for the analysis of farnesyltransferase inhibitors. J Med Chem (2000) 0.96
High expression of bcl-2 is the rule in acute lymphoblastic leukemia, except in Burkitt subtype at presentation, and is not correlated with the prognosis. Ann Hematol (1994) 0.95
The antileukemic alkaloid fagaronine is an inhibitor of DNA topoisomerases I and II. Biochem Pharmacol (1993) 0.94
[Induction of a "dyskinetoplast" by ethidium bromide in Trypanosoma cruzi cultivated in vitro]. C R Acad Sci Hebd Seances Acad Sci D (1967) 0.94
Cell cycle analysis and synchronization of the Xenopus cell line XL2. Exp Cell Res (1998) 0.94
Combined analysis of DNA ploidy index and N-myc genomic content in neuroblastoma. Cancer Res (1991) 0.93
The development of telomerase inhibitors: the G-quartet approach. Anticancer Drug Des (1999) 0.93
Coactivation of the MDR1 and MYCN genes in human neuroblastoma cells during the metastatic process in the nude mouse. Cancer Res (1994) 0.93
From amsacrine to DACA (N-[2-(dimethylamino)ethyl]acridine-4-carboxamide): selectivity for topoisomerases I and II among acridine derivatives. Eur J Cancer (1996) 0.93
Analysis of the c-Ha-ras-1 gene for deletion, mutation, amplification and expression in lymph node metastases of human head and neck carcinomas. Br J Cancer (1990) 0.93
c-myc, p53 and bcl-2, apoptosis-related genes in infiltrating breast carcinomas: evidence of a link between bcl-2 protein over-expression and a lower risk of metastasis and death in operable patients. Int J Cancer (1999) 0.92
Identification of a new metabolite of CPT-11 (irinotecan): pharmacological properties and activation to SN-38. J Pharmacol Exp Ther (1998) 0.92
HLA class II genotyping: two assay systems compared. Clin Chem (1995) 0.92
Molecular expression of PSMA mRNA and protein in primary renal tumors. Int J Cancer (1999) 0.92
Differential effects of amsacrine and epipodophyllotoxins on topoisomerase II cleavage in the human c-myc protooncogene. Cancer Res (1992) 0.91
Telomerase: a therapeutic target for the third millennium? Crit Rev Oncol Hematol (2000) 0.91